---
figid: PMC9335290__fgene-13-927541-g002
figtitle: 'CircRNA ITCH: Insight Into Its Role and Clinical Application Prospect in
  Tumor and Non-Tumor Diseases'
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC9335290
filename: fgene-13-927541-g002.jpg
figlink: /pmc/articles/PMC9335290/figure/F2/
number: F2
caption: Schematic diagram of anti-tumor mechanism of circ-ITCH. (A) via sponging
  miR-7, miR-17, miR-20a, miR-22-3p, and miR-214, circ-ITCH increases ITCH levels
  to inhibit Wnt signaling pathway in ESCC, CRC, LC, TNBC, PCa, HCC and GC; (B) via
  sponging miR-7, miR-14, miR-22, miR-145 and miR-224, circ-ITCH activate the inhibitory
  proteins (RASA1 and PTEN) of Erk and PI3K cascade to suppress the activation of
  these signaling pathway in BCa, OS, NPC and OC; (C) via sponging miR-17-5p, miR-421,
  miR-524, miR-660, miR-106a-5p, miR-224-5p, miR-93-5p and miR-199a-5p, circ-ITCH
  regulates cell cycle-related proteins to inhibit cell proliferation and promote
  cell apoptosis in PCa, OS, OSCC, HCC, ccRCC, CC, glioma, melanoma and GC; (D) Via
  sponging miR-184 and miR-199a-5p, circ-ITCH suppresses EMT process in HCC and GC;
  (E) In addition, circ-ITCH can directly regulate some proteins without specific
  target miRNAs. In a word, circ-ITCH plays an anti-tumor role by negatively regulating
  cell proliferation, invasion, migration, and positively regulating cell apoptosis.
papertitle: 'CircRNA ITCH: Insight Into Its Role and Clinical Application Prospect
  in Tumor and Non-Tumor Diseases.'
reftext: Tong Liu, et al. Front Genet. 2022;13:927541.
year: '2022'
doi: 10.3389/fgene.2022.927541
journal_title: Frontiers in Genetics
journal_nlm_ta: Front Genet
publisher_name: Frontiers Media S.A.
keywords: circ-ITCH | malignant tumor | non-tumor diseases | mechanism | biomarkers
automl_pathway: 0.9397181
figid_alias: PMC9335290__F2
figtype: Figure
redirect_from: /figures/PMC9335290__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9335290__fgene-13-927541-g002.html
  '@type': Dataset
  description: Schematic diagram of anti-tumor mechanism of circ-ITCH. (A) via sponging
    miR-7, miR-17, miR-20a, miR-22-3p, and miR-214, circ-ITCH increases ITCH levels
    to inhibit Wnt signaling pathway in ESCC, CRC, LC, TNBC, PCa, HCC and GC; (B)
    via sponging miR-7, miR-14, miR-22, miR-145 and miR-224, circ-ITCH activate the
    inhibitory proteins (RASA1 and PTEN) of Erk and PI3K cascade to suppress the activation
    of these signaling pathway in BCa, OS, NPC and OC; (C) via sponging miR-17-5p,
    miR-421, miR-524, miR-660, miR-106a-5p, miR-224-5p, miR-93-5p and miR-199a-5p,
    circ-ITCH regulates cell cycle-related proteins to inhibit cell proliferation
    and promote cell apoptosis in PCa, OS, OSCC, HCC, ccRCC, CC, glioma, melanoma
    and GC; (D) Via sponging miR-184 and miR-199a-5p, circ-ITCH suppresses EMT process
    in HCC and GC; (E) In addition, circ-ITCH can directly regulate some proteins
    without specific target miRNAs. In a word, circ-ITCH plays an anti-tumor role
    by negatively regulating cell proliferation, invasion, migration, and positively
    regulating cell apoptosis.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - RPSA
  - LRP1
  - PTPRA
  - MVP
  - ITK
  - SLC22A3
  - CTNNB1
  - CDH2
  - CDH1
  - FZR1
  - ITCH
  - PDCD4
  - HOXB13
  - PC
  - CCND1
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - BAX
  - CHMP2A
  - BLCAP
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - MTOR
  - KRAS
  - HRAS
  - NRAS
  - FOXK2
  - PTEN
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
---
